AU4596096A - Novel carbapenem derivative - Google Patents

Novel carbapenem derivative

Info

Publication number
AU4596096A
AU4596096A AU45960/96A AU4596096A AU4596096A AU 4596096 A AU4596096 A AU 4596096A AU 45960/96 A AU45960/96 A AU 45960/96A AU 4596096 A AU4596096 A AU 4596096A AU 4596096 A AU4596096 A AU 4596096A
Authority
AU
Australia
Prior art keywords
carbapenem derivative
novel carbapenem
novel
derivative
carbapenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45960/96A
Inventor
Hiroshi Fukatsu
Tomoyasu Kanesaka
Yoshiaki Kato
Susumu Nakagawa
Yuichi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU4596096A publication Critical patent/AU4596096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45960/96A 1994-09-06 1995-09-04 Novel carbapenem derivative Abandoned AU4596096A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP06-238484 1994-09-06
JP23848494 1994-09-06
JP7228095 1995-03-06
JP07-72280 1995-03-06
JP9501111 1995-06-06
WOJP9501111 1995-06-06
PCT/JP1995/001756 WO1996007655A1 (en) 1994-09-06 1995-09-04 Novel carbapenem derivative

Publications (1)

Publication Number Publication Date
AU4596096A true AU4596096A (en) 1996-03-27

Family

ID=27300918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45960/96A Abandoned AU4596096A (en) 1994-09-06 1995-09-04 Novel carbapenem derivative

Country Status (2)

Country Link
AU (1) AU4596096A (en)
WO (1) WO1996007655A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1059970A (en) * 1996-08-16 1998-03-03 Suntory Ltd Carbapenem derivative and antimicrobial agent containing the same
AU2003301425A1 (en) * 2002-10-18 2004-05-04 Meiji Seika Kaisha, Ltd. Process for producing carbapenem derivative and intermediate for use in the production
JP4101262B2 (en) 2005-10-11 2008-06-18 横浜ゴム株式会社 N-substituted succinimide thio group-containing carboxylate and unvulcanized rubber composition containing the same
WO2019140387A1 (en) 2018-01-12 2019-07-18 Kymera Therapeutics, Inc. Crbn ligands and uses thereof
US11292792B2 (en) 2018-07-06 2022-04-05 Kymera Therapeutics, Inc. Tricyclic CRBN ligands and uses thereof
KR20210111252A (en) 2018-11-30 2021-09-10 카이메라 쎄라퓨틱스 인코포레이티드 IRAK disintegrants and uses thereof
BR112022012410A2 (en) 2019-12-23 2022-08-30 Kymera Therapeutics Inc SMARCA DEGRADATORS AND USE THEREOF
IL296451A (en) 2020-03-19 2022-11-01 Kymera Therapeutics Inc Mdm2 degraders and uses thereof
TW202210483A (en) 2020-06-03 2022-03-16 美商凱麥拉醫療公司 Crystalline forms of irak degraders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717728A (en) * 1983-11-21 1988-01-05 Merck & Co., Inc. Cyclic amidinyl and cyclic guanidinyl thio carbapenems
JPH0745499B2 (en) * 1988-05-10 1995-05-17 三共株式会社 1-methylcarbapenem derivative
CA2050255C (en) * 1990-09-07 1997-02-04 Tameo Iwasaki 1-methylcarbapenem derivatives and process for preparation thereof

Also Published As

Publication number Publication date
WO1996007655A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
AU4036895A (en) Substituted 1H-imidazoles
AU3382595A (en) Novel compounds
AU2869495A (en) Zeolite ssz-41
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AUPN012194A0 (en) Alumino-silicate derivatives
AU4514496A (en) Novel compounds
AU2844595A (en) Substituted biphenyloxazolines
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
AU6010594A (en) Isoxazoleoxy derivative
AU2308295A (en) Heterocyclylbenzonitriles
AU4596096A (en) Novel carbapenem derivative
AU5347496A (en) Ethynylthiazole derivative
AU1963395A (en) Boom-structure
AU4117396A (en) Morpholinoethylamide derivatives
AU689566B2 (en) DC-89 derivatives
AU4399396A (en) Compounds
AU3619695A (en) Thioquinolone derivative
AU671899B2 (en) 5-O-desosaminylerythronolide derivative
AU1454895A (en) Diphenyloxazoline derivatives
AU4260296A (en) Novel pyrimidinyloxy- and pyrimidinylamino-ethylphenyl-dioxolane derivatives
AU4300696A (en) Substituted m-biphenyloxazoline derivatives
AU4912393A (en) 1-beta-methyl-2-thiolic carbapenem derivatives
AU3856995A (en) UCF116 Compounds
AU3648893A (en) Carbapenem derivative
AU691971B2 (en) Novel carbapenem derivative